Sponsor Pipeline

Guangdong Raynovent Biotech Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
11
Active Trials
3
Recruiting
5
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
5
Phase 2
3
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06893016 Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight Obesity Recruiting
NCT07139535 A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and… T2DM Not Yet Recruiting
NCT07139548 A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in… T2DM Not Yet Recruiting
NCT07229807 Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A Influenza a Active, Not Recruiting
NCT07229820 Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A Influenza A Active, Not Recruiting
Phase 2
NCT06254261 A Study of RAY1225 in Participants With Obesity Obesity Recruiting
NCT05692492 A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With… Nonalcoholic Steatohepatitis (NASH) Active, Not Recruiting
NCT06254274 A Study of RAY1225 in Participants With Type 2 Diabetes T2DM (Type 2 Diabetes Mellitus) Active, Not Recruiting
Phase 1
NCT06577415 A Study of RAY1225 in Participants With Impaired Liver Function Hepatic Impairment Recruiting
NCT07362030 Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin Obesity Active, Not Recruiting
NCT07460284 A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants Basic Science Not Yet Recruiting
Disease Areas
Get alerts when Guangdong Raynovent Biotech Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free